DCVC Opportunity Fund II GP, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001668343

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q2 2026 · 2 positions · Total reported value $17.20M · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 50.0% · 0 new · 1 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, DCVC Opportunity Fund II GP, LLC disclosed 2 equity positions with a combined reported value of $17.20M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were RXRX ($14.50M), IONQ ($2.70M). By sector, the heaviest allocations are Health Care 84.3%, Technology 15.7%. Versus the prior quarter, allocation shifted toward Technology (+3.2pp) and away from Health Care (-3.2pp).

Versus the prior quarter, DCVC Opportunity Fund II GP, LLC opened 0 new positions, trimmed 1 and fully exited 0, a turnover rate of 50.0% of positions. The portfolio's overlap with the prior quarter was 100% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

Insider Transactions (Form 4)

Latest DCVC Opportunity Fund II GP, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

DCVC Opportunity Fund II GP, LLC files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 2 positions worth $17.20M in total. HoldingsHub carries 11 quarters of its filings (Q4 2023–Q2 2026).

Portfolio Structure

  • 2 positions · $17.20M reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: RXRX (RECURSION PHARMACEUTICALCLASS A) at 84.3%
  • Average position size: $8.60M

Sector Tilt

  • Health Care 84.3%
  • Information Technology 15.7%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 1 reduced
  • 1 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund appears to maintain a cautious stance, with a slight reduction in exposure to IONQ, possibly indicating a preference for more stable or established companies in the Health Care sector. 2. Key Moves: - No New Positions: The fund did not add any new positions this quarter. - IONQ Reduction: Reduced the position in IONQ by 15.8%, from 60,226 shares to 50,705 shares, indicating a shift away from Technology. - No Change in RXRX: The position in RXRX remained unchanged, suggesting confidence in the company's prospects. 3. Portfolio Structure: - Passive vs. Active: The fund's approach seems to be more passive, with a focus on maintaining existing positions rather than actively seeking out new opportunities. - Sector Bias: The portfolio is heavily biased towards the Health Care sector, with RXRX accounting for 84.30% of the total value. - Risk Appetite: The fund's risk appetite appears moderate, with a preference for stable, established companies over high-growth, high-risk ones. 4. Per-Holding One-Liner: - RXRX (RECURSION PHARMACEUTICALS): Biotechnology company focused on developing treatments for cancer. - IONQ (IONQ INC): Technology company specializing in quantum computing applications. 5. One-Sentence Style Summary: The DCVC Opportunity Fund II GP, LLC maintained a conservative approach in Q2 2026, focusing on a stable Health Care position while reducing exposure to the Technology sector.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 84.3%
Technology 15.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 3.95M $14.50M 84.30%
84.30%
Hold
2 50.70K $2.70M 15.70%
15.70%
Reduce

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 100% R 100% F1 100% (modelled on 2026-Q1; 2/10 hit)

Historical Backtest (9 quarters)

Avg precision 91% · recall 94% · F1 90% · avg rank error 1.5 · Top-10 turnover 11%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q2 100% 100% 100% RXRX · RKLB · RGTI RKLB · RXRX · RGTI
2024-Q3 100% 100% 100% RKLB · RXRX · RGTI RKLB · RXRX · RGTI
2024-Q4 67% 100% 80% RKLB · RXRX · RGTI RKLB · RXRX
2025-Q1 100% 100% 100% RKLB · RXRX RKLB · RXRX
2025-Q2 100% 100% 100% RKLB · RXRX RKLB · RXRX
2025-Q3 50% 100% 67% RKLB · RXRX RXRX
2025-Q4 100% 50% 67% RXRX RXRX · IONQ
2026-Q1 100% 100% 100% RXRX · IONQ RXRX · IONQ
2026-Q2 ★ 100% 100% 100% RXRX · IONQ RXRX · IONQ

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did DCVC Opportunity Fund II GP, LLC buy in 2026-Q2?

In its 2026-Q2 13F filing, DCVC Opportunity Fund II GP, LLC reported 2 equity positions worth $17.20M in aggregate; its largest disclosed positions were RXRX ($14.50M), IONQ ($2.70M).

How large is DCVC Opportunity Fund II GP, LLC's portfolio?

DCVC Opportunity Fund II GP, LLC reported $17.20M of long equity holdings across 2 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is DCVC Opportunity Fund II GP, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/dcvc-opportunity-fund-ii-gp/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →